Clinuvel Pharmaceuticals Preparing Upgrade Of ADR Program To Level II, Nasdaq Uplist
Aug 22 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:
PREPARING UPGRADE OF ADR PROGRAM TO LEVEL II, NASDAQ UPLIST
PRIMARY LISTING ON ASX WILL REMAIN UNCHANGED
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.